SEC Comment Letter 0000000000-25-003935 to PAVmed Inc. (PAVM)
PAVmed Inc.
Date: April 14, 2025 · CIK: 0001624326 · Accession: 0000000000-25-003935
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-286442
Letter
Re: PAVmed Inc. Registration Statement on Form S-3 Filed April 8, 2025 File No. 333-286442 Dear Lishan Aklog:
April 14, 2025
Lishan Aklog Chairman of the Board and Chief Executive Officer PAVmed Inc. 405 Lexington Avenue 44th Floor New York, New York 10174
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Robert Augustin at 202-551-8483 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Industrial
Applications and
Services
cc: Eric T. Schwartz
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> April 14, 2025 Lishan Aklog Chairman of the Board and Chief Executive Officer PAVmed Inc. 405 Lexington Avenue 44th Floor New York, New York 10174 Re: PAVmed Inc. Registration Statement on Form S-3 Filed April 8, 2025 File No. 333-286442 Dear Lishan Aklog: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Robert Augustin at 202-551-8483 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Eric T. Schwartz </TEXT> </DOCUMENT>